Real-World Use of Biologics and Prescription Topical Medications in Pediatric Psoriasis in a Large Dermatology Network in the U.S.

Related Articles

• The Next Generation of Registries and Real-World Evidence

  December 6, 2016June 6, 2017 | Webinars

• RW Data for Rheumatologic and Related Disorders: Navigating the path to approval, reimbursement and usage

  January 17, 2017June 9, 2017 | Webinars

• Outcomes as the Key to Value-based Healthcare: Going From Real World Evidence to Outcomes-Based Contracts

  March 9, 2017July 15, 2017 | Webinars